centchroman has been researched along with daidzein in 1 studies
| Studies (centchroman) | Trials (centchroman) | Recent Studies (post-2010) (centchroman) | Studies (daidzein) | Trials (daidzein) | Recent Studies (post-2010) (daidzein) |
|---|---|---|---|---|---|
| 157 | 12 | 47 | 1,885 | 136 | 753 |
| Protein | Taxonomy | centchroman (IC50) | daidzein (IC50) |
|---|---|---|---|
| rac GTPase-activating protein 1 isoform a | Homo sapiens (human) | 91.26 | |
| Estrogen receptor | Homo sapiens (human) | 2.97 | |
| Aldehyde dehydrogenase, mitochondrial | Homo sapiens (human) | 9 | |
| UDP-glucuronosyltransferase 1A1 | Homo sapiens (human) | 7.3 | |
| Transporter | Rattus norvegicus (Norway rat) | 0.45 | |
| Estrogen receptor beta | Homo sapiens (human) | 1.6568 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balapure, AK; Kaushik, S; Sharma, R; Shyam, H | 1 |
1 other study(ies) available for centchroman and daidzein
| Article | Year |
|---|---|
Dietary isoflavone daidzein synergizes centchroman action via induction of apoptosis and inhibition of PI3K/Akt pathway in MCF-7/MDA MB-231 human breast cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Survival; Centchroman; Drug Synergism; Female; Humans; Isoflavones; MCF-7 Cells; Membrane Potential, Mitochondrial; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases | 2018 |